Clinical Trial

Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

Name: Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube — clinical trial record (NCT07556484)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the 72-hour pharmacokinetics of emulsified avacopan at a dose of 30 mg twice daily given to up to 6 patients with active severe GPA or MPA with diffuse alveolar hemorrhage (DAH) requiring mechanical ventilation for respiratory support.

Trial Details

NCT Number	NCT07556484
Lead Sponsor	Mayo Clinic
Conditions	Diffuse Alveolar Hemorrhage, Antineutrophil Cytoplasmic Antibody Positive Vasculitis
Enrollment	6 participants
Start Date	2026-08-01
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-06